Reported 2 days ago
23andMe, facing Chapter 11 bankruptcy, has announced plans to sell its vast repository of genetic data, sparking privacy concerns among its 15 million users. Genetic data, offering insights into health and personal preferences, is attractive to corporations for personalized marketing and medical research. Experts warn of potential misuse, as laws protecting against genetic discrimination are limited. While 23andMe assures that user data handling will remain unchanged, the future of genetic privacy hangs in the balance.
Source: YAHOO